表紙
市場調查報告書

學名藥:全球產業年鑑

Generics Global Industry Almanac 2014-2023

出版商 MarketLine 商品編碼 353039
出版日期 內容資訊 英文 490 Pages
訂單完成後即時交付
價格
學名藥:全球產業年鑑 Generics Global Industry Almanac 2014-2023
出版日期: 2020年02月26日內容資訊: 英文 490 Pages
簡介

本報告提供全球無酒精飲品產業分析,提供您各國和各地市場規模,部門,市場預測等等,加上主要企業簡介,為您概述為以下內容。

摘要整理

  • 市場銷售額
  • 市場銷售額的預測
  • 市場交易數量
  • 市場交易數量的預測
  • 地區部門

簡介

  • 關於本報告
  • 主要讀者
  • 該報告的利用方法
  • 定義

全球GENERICS

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析

GENERICS:亞太地區

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析

GENERICS:歐洲

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析

GENERICS:法國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:德國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:澳洲

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:巴西

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:加拿大

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:中國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:印度

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS :印尼

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:義大利

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:日本

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS :墨西哥

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:荷蘭

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:北美

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析

GENERICS:俄羅斯

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:斯堪地那維亞

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析

GENERICS:新加坡

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:南非

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:韓國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:西班牙

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:土耳其

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:英國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

GENERICS:美國

  • 市場概要
  • 市場資料
  • 市場區隔
  • 市場展望
  • 波特的五力分析
  • 宏觀經濟指標

企業簡介

  • 主要企業

附錄

  • 調查手法
  • MarketLine

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MLIG190037-01

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the global generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The market value is evaluated at ex-factory prices.

Market volume is quantified here as the percentage of the total ethical pharmaceutical market volume in a country or region which is accounted for by generic drugs. It is therefore a generics penetration rate measure, not an absolute measure of market volume.

Regional volumes are calculated as weighted averages of countries which make up the region in question where volume data exists.

Note that any volumes of "1" (one) or 100% are due to rounding as MarketLine does not believe that generics will ever fully represent 100% of the medicinal market in any country or region.

All currency conversions were calculated at constant average annual 2018 exchange rates.

The global generics market had total revenues of $328.4bn in 2018, representing a compound annual growth rate (CAGR) of 7.1% between 2014 and 2018.

Market consumption volume increased with a CAGR of 2.3% between 2014 and 2018, to reach 61.8% of total pharma volume in 2018.

Growth is expected to remain strong even though the global market will experience a gradual deceleration during the forecast period. The continued expansion is being boosted by countries with an aging population and increased urbanization.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the global generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global generics market
  • Leading company profiles reveal details of key generics market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global generics market with five year forecasts by both value and volume
  • Reasons to buy
  • What was the size of the global generics market by value in 2018?
  • What will be the size of the global generics market in 2023?
  • What factors are affecting the strength of competition in the global generics market?
  • How has the market performed over the last five years?
  • How large is the global generics market in relation to its regional counterparts?

Table of Contents

1 EXECUTIVE SUMMARY

  • 1.1. Market value
  • 1.2. Market value forecast
  • 1.3. Market volume
  • 1.4. Market volume forecast
  • 1.5. Geography segmentation
  • 1.6. Competitive Landscape

2 Introduction

  • 2.1. What is this report about?
  • 2.2. Who is the target reader?
  • 2.3. How to use this report
  • 2.4. Definitions

3 Global Generics

  • 3.1. Market Overview
  • 3.2. Market Data
  • 3.3. Market Segmentation
  • 3.4. Market outlook
  • 3.5. Five forces analysis
  • 3.6. Macroeconomic Indicators
  • 3.7. Country data

4 Generics in Asia-Pacific

  • 4.1. Market Overview
  • 4.2. Market Data
  • 4.3. Market Segmentation
  • 4.4. Market outlook
  • 4.5. Five forces analysis

5 Generics in Europe

  • 5.1. Market Overview
  • 5.2. Market Data
  • 5.3. Market Segmentation
  • 5.4. Market outlook
  • 5.5. Five forces analysis
  • 5.6. Macroeconomic Indicators
  • 5.7. Country data

6 Generics in France

  • 6.1. Market Overview
  • 6.2. Market Data
  • 6.3. Market Segmentation
  • 6.4. Market outlook
  • 6.5. Five forces analysis
  • 6.6. Macroeconomic Indicators
  • 6.7. Country data

7 Generics in Germany

  • 7.1. Market Overview
  • 7.2. Market Data
  • 7.3. Market Segmentation
  • 7.4. Market outlook
  • 7.5. Five forces analysis
  • 7.6. Macroeconomic Indicators
  • 7.7. Country data

8 Generics in Australia

  • 8.1. Market Overview
  • 8.2. Market Data
  • 8.3. Market Segmentation
  • 8.4. Market outlook
  • 8.5. Five forces analysis
  • 8.6. Macroeconomic Indicators
  • 8.7. Country data

9 Generics in Brazil

  • 9.1. Market Overview
  • 9.2. Market Data
  • 9.3. Market Segmentation
  • 9.4. Market outlook
  • 9.5. Five forces analysis
  • 9.6. Macroeconomic Indicators
  • 9.7. Country data

10 Generics in Canada

  • 10.1. Market Overview
  • 10.2. Market Data
  • 10.3. Market Segmentation
  • 10.4. Market outlook
  • 10.5. Five forces analysis
  • 10.6. Macroeconomic Indicators
  • 10.7. Country data

11 Generics in China

  • 11.1. Market Overview
  • 11.2. Market Data
  • 11.3. Market Segmentation
  • 11.4. Market outlook
  • 11.5. Five forces analysis
  • 11.6. Macroeconomic Indicators
  • 11.7. Country data

12 Generics in India

  • 12.1. Market Overview
  • 12.2. Market Data
  • 12.3. Market Segmentation
  • 12.4. Market outlook
  • 12.5. Five forces analysis
  • 12.6. Macroeconomic Indicators
  • 12.7. Country data

13 Generics in Indonesia

  • 13.1. Market Overview
  • 13.2. Market Data
  • 13.3. Market Segmentation
  • 13.4. Market outlook
  • 13.5. Five forces analysis
  • 13.6. Macroeconomic Indicators
  • 13.7. Country data

14 Generics in Italy

  • 14.1. Market Overview
  • 14.2. Market Data
  • 14.3. Market Segmentation
  • 14.4. Market outlook
  • 14.5. Five forces analysis
  • 14.6. Macroeconomic Indicators
  • 14.7. Country data

15 Generics in Japan

  • 15.1. Market Overview
  • 15.2. Market Data
  • 15.3. Market Segmentation
  • 15.4. Market outlook
  • 15.5. Five forces analysis
  • 15.6. Macroeconomic Indicators
  • 15.7. Country data

16 Generics in Mexico

  • 16.1. Market Overview
  • 16.2. Market Data
  • 16.3. Market Segmentation
  • 16.4. Market outlook
  • 16.5. Five forces analysis
  • 16.6. Macroeconomic Indicators
  • 16.7. Country data

17 Generics in the Netherlands

  • 17.1. Market Overview
  • 17.2. Market Data
  • 17.3. Market Segmentation
  • 17.4. Market outlook
  • 17.5. Five forces analysis
  • 17.6. Macroeconomic Indicators
  • 17.7. Country data

18 Generics in North America

  • 18.1. Market Overview
  • 18.2. Market Data
  • 18.3. Market Segmentation
  • 18.4. Market outlook
  • 18.5. Five forces analysis

19 Generics in Russia

  • 19.1. Market Overview
  • 19.2. Market Data
  • 19.3. Market Segmentation
  • 19.4. Market outlook
  • 19.5. Five forces analysis
  • 19.6. Macroeconomic Indicators
  • 19.7. Country data

20 Generics in Scandinavia

  • 20.1. Market Overview
  • 20.2. Market Data
  • 20.3. Market Segmentation
  • 20.4. Market outlook
  • 20.5. Five forces analysis

21 Generics in Singapore

  • 21.1. Market Overview
  • 21.2. Market Data
  • 21.3. Market Segmentation
  • 21.4. Market outlook
  • 21.5. Five forces analysis
  • 21.6. Macroeconomic Indicators
  • 21.7. Country data

22 Generics in South Africa

  • 22.1. Market Overview
  • 22.2. Market Data
  • 22.3. Market Segmentation
  • 22.4. Market outlook
  • 22.5. Five forces analysis
  • 22.6. Macroeconomic Indicators
  • 22.7. Country data

23 Generics in South Korea

  • 23.1. Market Overview
  • 23.2. Market Data
  • 23.3. Market Segmentation
  • 23.4. Market outlook
  • 23.5. Five forces analysis
  • 23.6. Macroeconomic Indicators
  • 23.7. Country data

24 Generics in Spain

  • 24.1. Market Overview
  • 24.2. Market Data
  • 24.3. Market Segmentation
  • 24.4. Market outlook
  • 24.5. Five forces analysis
  • 24.6. Macroeconomic Indicators
  • 24.7. Country data

25 Generics in Turkey

  • 25.1. Market Overview
  • 25.2. Market Data
  • 25.3. Market Segmentation
  • 25.4. Market outlook
  • 25.5. Five forces analysis
  • 25.6. Macroeconomic Indicators
  • 25.7. Country data

26 Generics in the United Kingdom

  • 26.1. Market Overview
  • 26.2. Market Data
  • 26.3. Market Segmentation
  • 26.4. Market outlook
  • 26.5. Five forces analysis
  • 26.6. Macroeconomic Indicators
  • 26.7. Country data

27 Generics in the United States

  • 27.1. Market Overview
  • 27.2. Market Data
  • 27.3. Market Segmentation
  • 27.4. Market outlook
  • 27.5. Five forces analysis
  • 27.6. Macroeconomic Indicators
  • 27.7. Country data

28 Company Profiles

  • 28.1. Teva Pharmaceutical Industries Limited
  • 28.2. Pfizer Inc.
  • 28.3. Mylan N.V.
  • 28.4. Sun Pharmaceutical Industries Ltd
  • 28.5. Sanofi SA
  • 28.6. Les Laboratoires Servier
  • 28.7. STADA Arzneimittel AG
  • 28.8. Aspen Pharmacare Holdings Ltd
  • 28.9. Apotex, Inc.

28.10. EMS SA

  • 28.11. Ache Laboratorios Farmaceuticos SA
  • 28.12. Eurofarma Laboratorios SA
  • 28.13. China Grand Pharmaceutical and Healthcare Holdings Limited
  • 28.14. Aurobindo Pharma Ltd
  • 28.15. Cipla Limited
  • 28.16. PT Kalbe Farma Tbk
  • 28.17. PT Sanbe Farma
  • 28.18. SOHO Global Health
  • 28.19. PT Indofarma (Persero), Tbk
  • 28.20. Daiichi Sankyo Co Ltd
  • 28.21. Sawai Pharmaceutical Co Ltd
  • 28.22. Lupin Ltd
  • 28.23. Krka, d. d., Novo mesto
  • 28.24. Abbott Laboratories
  • 28.25. Adcock Ingram Holdings Ltd
  • 28.26. Yuhan Corp
  • 28.27. Esteve Group
  • 28.28. Deva Holding AS
  • 28.29. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
  • 28.30. Nobelpharma Co Ltd

Appendix

List of Tables

  • Table 1: Global generics market value: $ million, 2014-18
  • Table 2: Global generics market volume: % of total pharma, 2014-18
  • Table 3: Global generics market geography segmentation: $ million, 2018
  • Table 4: Global generics market value forecast: $ million, 2018-23
  • Table 5: Global generics market volume forecast: % of total pharma, 2018-23
  • Table 6: Global size of population (million), 2014-18
  • Table 7: Global gdp (constant 2005 prices, $ billion), 2014-18
  • Table 8: Global gdp (current prices, $ billion), 2014-18
  • Table 9: Global inflation, 2014-18
  • Table 10: Global consumer price index (absolute), 2014-18
  • Table 11: Global exchange rate, 2014-18
  • Table 12: Asia-Pacific generics market value: $ million, 2014-18
  • Table 13: Asia-Pacific generics market volume: % of total pharma, 2014-18
  • Table 14: Asia-Pacific generics market geography segmentation: $ million, 2018
  • Table 15: Asia-Pacific generics market value forecast: $ million, 2018-23
  • Table 16: Asia-Pacific generics market volume forecast: % of total pharma, 2018-23
  • Table 17: Europe generics market value: $ million, 2014-18
  • Table 18: Europe generics market volume: % of total pharma, 2014-18
  • Table 19: Europe generics market geography segmentation: $ million, 2018
  • Table 20: Europe generics market value forecast: $ million, 2018-23
  • Table 21: Europe generics market volume forecast: % of total pharma, 2018-23
  • Table 22: Europe size of population (million), 2014-18
  • Table 23: Europe gdp (constant 2005 prices, $ billion), 2014-18
  • Table 24: Europe gdp (current prices, $ billion), 2014-18
  • Table 25: Europe inflation, 2014-18
  • Table 26: Europe consumer price index (absolute), 2014-18
  • Table 27: Europe exchange rate, 2014-18
  • Table 28: France generics market value: $ million, 2014-18
  • Table 29: France generics market volume: % of total pharma, 2014-18
  • Table 30: France generics market geography segmentation: $ million, 2018
  • Table 31: France generics market value forecast: $ million, 2018-23
  • Table 32: France generics market volume forecast: % of total pharma, 2018-23
  • Table 33: France size of population (million), 2014-18
  • Table 34: France gdp (constant 2005 prices, $ billion), 2014-18
  • Table 35: France gdp (current prices, $ billion), 2014-18
  • Table 36: France inflation, 2014-18
  • Table 37: France consumer price index (absolute), 2014-18
  • Table 38: France exchange rate, 2014-18
  • Table 39: Germany generics market value: $ million, 2014-18
  • Table 40: Germany generics market volume: % of total pharma, 2014-18
  • Table 41: Germany generics market geography segmentation: $ million, 2018
  • Table 42: Germany generics market value forecast: $ million, 2018-23
  • Table 43: Germany generics market volume forecast: % of total pharma, 2018-23
  • Table 44: Germany size of population (million), 2014-18
  • Table 45: Germany gdp (constant 2005 prices, $ billion), 2014-18
  • Table 46: Germany gdp (current prices, $ billion), 2014-18
  • Table 47: Germany inflation, 2014-18
  • Table 48: Germany consumer price index (absolute), 2014-18
  • Table 49: Germany exchange rate, 2014-18
  • Table 50: Australia generics market value: $ million, 2014-18
  • Table 51: Australia generics market volume: % of total pharma, 2014-18
  • Table 52: Australia generics market geography segmentation: $ million, 2018
  • Table 53: Australia generics market value forecast: $ million, 2018-23
  • Table 54: Australia generics market volume forecast: % of total pharma, 2018-23
  • Table 55: Australia size of population (million), 2014-18
  • Table 56: Australia gdp (constant 2005 prices, $ billion), 2014-18
  • Table 57: Australia gdp (current prices, $ billion), 2014-18
  • Table 58: Australia inflation, 2014-18
  • Table 59: Australia consumer price index (absolute), 2014-18
  • Table 60: Australia exchange rate, 2014-18

List of Figures

  • Figure 1: Global generics market value: $ million, 2014-18
  • Figure 2: Global generics market volume: % of total pharma, 2014-18
  • Figure 3: Global generics market geography segmentation: % share, by value, 2018
  • Figure 4: Global generics market value forecast: $ million, 2018-23
  • Figure 5: Global generics market volume forecast: % of total pharma, 2018-23
  • Figure 6: Forces driving competition in the global generics market, 2018
  • Figure 7: Drivers of buyer power in the global generics market, 2018
  • Figure 8: Drivers of supplier power in the global generics market, 2018
  • Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2018
  • Figure 10: Factors influencing the threat of substitutes in the global generics market, 2018
  • Figure 11: Drivers of degree of rivalry in the global generics market, 2018
  • Figure 12: Asia-Pacific generics market value: $ million, 2014-18
  • Figure 13: Asia-Pacific generics market volume: % of total pharma, 2014-18
  • Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2018
  • Figure 15: Asia-Pacific generics market value forecast: $ million, 2018-23
  • Figure 16: Asia-Pacific generics market volume forecast: % of total pharma, 2018-23
  • Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2018
  • Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2018
  • Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2018
  • Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2018
  • Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2018
  • Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2018
  • Figure 23: Europe generics market value: $ million, 2014-18
  • Figure 24: Europe generics market volume: % of total pharma, 2014-18
  • Figure 25: Europe generics market geography segmentation: % share, by value, 2018
  • Figure 26: Europe generics market value forecast: $ million, 2018-23
  • Figure 27: Europe generics market volume forecast: % of total pharma, 2018-23
  • Figure 28: Forces driving competition in the generics market in Europe, 2018
  • Figure 29: Drivers of buyer power in the generics market in Europe, 2018
  • Figure 30: Drivers of supplier power in the generics market in Europe, 2018
  • Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2018
  • Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2018
  • Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2018
  • Figure 34: France generics market value: $ million, 2014-18
  • Figure 35: France generics market volume: % of total pharma, 2014-18
  • Figure 36: France generics market geography segmentation: % share, by value, 2018
  • Figure 37: France generics market value forecast: $ million, 2018-23
  • Figure 38: France generics market volume forecast: % of total pharma, 2018-23
  • Figure 39: Forces driving competition in the generics market in France, 2018
  • Figure 40: Drivers of buyer power in the generics market in France, 2018
  • Figure 41: Drivers of supplier power in the generics market in France, 2018
  • Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2018
  • Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2018
  • Figure 44: Drivers of degree of rivalry in the generics market in France, 2018
  • Figure 45: Germany generics market value: $ million, 2014-18
  • Figure 46: Germany generics market volume: % of total pharma, 2014-18
  • Figure 47: Germany generics market geography segmentation: % share, by value, 2018
  • Figure 48: Germany generics market value forecast: $ million, 2018-23
  • Figure 49: Germany generics market volume forecast: % of total pharma, 2018-23
  • Figure 50: Forces driving competition in the generics market in Germany, 2018
  • Figure 51: Drivers of buyer power in the generics market in Germany, 2018
  • Figure 52: Drivers of supplier power in the generics market in Germany, 2018
  • Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2018
  • Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2018
  • Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2018
  • Figure 56: Australia generics market value: $ million, 2014-18
  • Figure 57: Australia generics market volume: % of total pharma, 2014-18
  • Figure 58: Australia generics market geography segmentation: % share, by value, 2018
  • Figure 59: Australia generics market value forecast: $ million, 2018-23